The postgenomic receptor & ligand company
Reagents for Angiogenic and Lymphangiogenic Research
ReliaTech is a primary manufacturer of polyclonal and monoclonal antibodies as well as the production of growth factors and soluble receptors for angiogenic and lymphangiogenic research, cell surface receptors and their ligands. Founded in 1999 specializing in the field of VEGR research, they have recently added:
- Human VEGFR-2 (sKDR) and mouse VEGFR-2 (sFlk-1)
o PAbs directed against the unique C-terminal end of both soluble receptors, recognizing solely the natie receptor but not the membrane bound form. - svVEGF-F (also named VR-1 and Vammin) cloned from snakes
- PAbs to human CCM-1, CCM-2 and CCM-3 (Cerebral cavernous malformations 1-3 proteins), and human ESAM (Endothelial cell-selective adhesion molecule) and human ccbe1 (Collagen and calcium-binding EGF domain-containing protein 1)
- MAb to human CEACAM-1 (Carcinoembryonic Antigen-related Cell Adhesion Molecule 1) a molecule described in lymphangiogenesis
- Human and Mouse Gremlin 1 and Emilin 1 & 2 proteins and antibodies
- Mouse sTIE1 protein and antibody
- Human and Mouse sTIE2 protein and antibody
RELIATech GmbH
Lindenerstr. 15, 3rd Floor
D-38300 Wolfenbüttel
Germany
Phone: + 49 5331-8586 987
Fax: + 49 5331-8586 989